William D. Essman

1990-1996 Psychiatry University of Pennsylvania, Philadelphia, PA, United States 
"William Essman"
Mean distance: 16.35 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wickett A, Essman W, Beck-Jennings J, et al. (2006) Cluster B and C personality traits, symptom correlates, and treatment utilization in postacute schizophrenia Journal of Nervous and Mental Disease. 194: 650-653
Rush CR, Essman WD, Simpson CA, et al. (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. Journal of Clinical Psychopharmacology. 21: 273-86
Vanecek SA, Essman WD, Taylor DP, et al. (1998) Discriminative stimulus characteristics of BMY 14802 in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 284: 1-9
Kung MP, Stevenson DA, Plössl K, et al. (1997) [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. European Journal of Nuclear Medicine. 24: 372-80
Essman WD, Luedtke RR, McGonigle P, et al. (1995) Variations in the behavioral responses to apomorphine in different strains of rats. Behavioural Pharmacology. 6: 4-15
Kung MP, Essman WD, Frederick D, et al. (1995) IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse (New York, N.Y.). 20: 316-24
Essman WD, Singh A, Lucki I. (1994) Serotonergic properties of cocaine: effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine. Pharmacology, Biochemistry, and Behavior. 49: 107-13
Essman WD, McGonigle P, Lucki I. (1993) Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology. 112: 233-41
Woods JH, Bertalmio AJ, Young AM, et al. (1988) Receptor mechanisms of opioid drug discrimination. Psychopharmacology Series. 4: 95-106
See more...